FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, W. Y.
Right arrow Articles by Fischer, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, W. Y.
Right arrow Articles by Fischer, S. M.

The FASEB Journal, Vol 8, 1081-1087, Copyright © 1994 by The Federation of American Societies for Experimental Biology


RESEARCH COMMUNICATIONS

Interleukin-1 alpha mediates phorbol ester-induced inflammation and epidermal hyperplasia

WY Lee, MF Lockniskar and SM Fischer
Division of Pharmacology/Toxicology, College of Pharmacy, University of Texas at Austin 78712.

The topical application of the tumor promoter 12-O-tetradecanoylphorbol- 13-acetate (TPA) to murine skin produces acute inflammatory and hyperplastic responses that have been associated with the promotion stage of skin carcinogenesis. It has been shown in a previous study that TPA induces the expression of the highly inflammatory cytokine, interleukin (IL) -1 alpha, in the epidermis of SENCAR mice. The goal of this study was to investigate the role of IL-1 alpha in several TPA- induced responses in skin. Topical application of TPA (1 microgram) enhanced the production of immunoreactive IL-1 alpha protein, primarily associated with the suprabasal keratinocytes. IL-1 alpha intradermally injected in the dorsal surface significantly increased (P < 0.001) vascular permeability at low concentrations (1-1000 microU) and increased (P < 0.001) inflammatory cell infiltration and epidermal hyperplasia at higher concentrations (10(3) U). TPA produced fourfold increases in vascular permeability as measured by Evans blue dye leakage; this effect was prevented by intradermal injection of anti-IL- 1 alpha antibody (25-75 micrograms). Furthermore, injected anti-IL-1 alpha antibody significantly reduced (P < 0.001) TPA-induced inflammatory cell infiltration and epidermal hyperplasia. This study suggests that IL-1 alpha directly or indirectly mediates the inflammatory and hyperplastic responses elicited by topical treatment with TPA.


This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Ikuta, H. Edamatsu, M. Li, L. Hu, and T. Kataoka
Crucial Role of Phospholipase C{varepsilon} in Skin Inflammation Induced by Tumor-Promoting Phorbol Ester
Cancer Res., January 1, 2008; 68(1): 64 - 72.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Li, J. Eckard, R. Shah, C. Malluck, and K. Frenkel
Interleukin-1{alpha} Up-Regulation in Vivo by a Potent Carcinogen 7,12-Dimethylbenz(a)anthracene (DMBA) and Control of DMBA-induced Inflammatory Responses
Cancer Res., January 1, 2002; 62(2): 417 - 423.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. Arsenijevic, L. Girardier, J. Seydoux, J. C. Pechere, I. Garcia, R. Lucas, H. R. Chang, and A. G. Dulloo
Metabolic-cytokine responses to a second immunological challenge with LPS in mice with T. gondii infection
Am J Physiol Endocrinol Metab, March 1, 1998; 274(3): E439 - E445.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Rauschmayr, R. W. Groves, and T. S. Kupper
Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation
PNAS, May 27, 1997; 94(11): 5814 - 5819.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by The Federation of American Societies for Experimental Biology.